Breast Cancer Clinical Trials in Las Vegas, NV

Breast Cancer Clinical Trials in Las Vegas, NV

View the best 10 breast cancer medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Breast Cancer clinical trial.

Trials in Las Vegas, Nevada

Here are the top 10 medical studies for breast cancer in Las Vegas, Nevada

Image of Alaska Oncology and Hematology in Anchorage, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting4 awardsPhase 3
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of NRG Oncology in Philadelphia, United States.

Fulvestrant

Hormone Therapy

Recruiting1 awardPhase 2
This trial is testing whether adding binimetinib to the usual treatment of fulvestrant can help patients with a specific type of advanced breast cancer. Fulvestrant works by blocking estrogen receptors on cancer cells, while binimetinib stops enzymes that help cancer grow. The goal is to see if this combination can better control the cancer compared to using fulvestrant alone.
Image of Nevada Cancer Institute in Las Vegas, United States.

Exercise Regimen

Behavioural Intervention

Recruiting1 award6 criteria
This trial will compare the outcomes of two groups, one of which will receive a physical activity intervention while the other will only receive limited information on activity.
Image of University of California, San Francisco in San Francisco, United States.

Atorvastatin +1 More

HMG-CoA reductase inhibitor

Recruiting2 awardsPhase 2
This trial is testing whether the cholesterol-lowering medication atorvastatin can reduce the risk of breast cancer.
Image of University of Alabama at Birmingham/ Kirklin Clinic in Birmingham, United States.

Endocrine Therapy

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing a new drug to see if it is effective and safe to use in patients with a certain type of breast cancer.
Image of Carle Cancer Center in Urbana, United States.

Denosumab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing whether denosumab can prevent breast cancer in women with a BRCA1 gene mutation, which is linked to a higher risk of developing the disease.
Image of Birmingham Hematology and Oncology in Birmingham, United States.

Irinotecan +1 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is testing a combination of drugs to treat metastatic breast cancer, with or without the drug Erbitux.
Image of HonorHealth Research Institute - Bisgrove in Scottsdale, United States.

Autogene Cevumeran +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial tests a personalized cancer vaccine and an immune-boosting drug in cancer patients. The vaccine teaches the body to attack cancer, while the drug helps immune cells find and kill hidden cancer cells. This approach aims to induce strong anti-tumor responses by selecting suitable vaccines based on the patient's existing immune system.
Image of Research Site in Jonesboro, United States.

Durvalumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.